Loading...
Please wait, while we are loading the content...
Similar Documents
FLOT ist Chemotherapiestandard bei Adenokarzinomen des gastroösophagealen Übergangs und Magens in der Neoadjuvanz
| Content Provider | Scilit |
|---|---|
| Author | Treese, Christoph Harloff, Hannah Daum, Severin |
| Copyright Year | 2017 |
| Description | Al-Batran S et al. Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial. Lancet Oncol 2016; 17(12): 1697 – 1708 Al-Batran S et al. Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial. J Clin Oncol 2017; 35, no. 15 suppl. (May 2017) 4004 – 4004 |
| Related Links | http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0043-117060.pdf |
| Ending Page | 882 |
| Page Count | 2 |
| Starting Page | 881 |
| ISSN | 00442771 |
| e-ISSN | 14397803 |
| DOI | 10.1055/s-0043-117060 |
| Journal | Zeitschrift Fur Gastroenterologie |
| Issue Number | 09 |
| Volume Number | 55 |
| Language | English |
| Publisher | Georg Thieme Verlag KG |
| Publisher Date | 2017-09-12 |
| Access Restriction | Open |
| Subject Keyword | Journal: Zeitschrift Fur Gastroenterologie |
| Content Type | Text |
| Resource Type | Article |
| Subject | Gastroenterology |
